NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Software
Written by / Agency / Source: APTEAN
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Aptean Launches New, First-to-Market Antibody Search Solution to Support Biologics Research and Development - Unique Functionality Now Available within Aptean GenomeQuest, the World’s Leading Intellectual Property Sequence Database - Aptean.com
Aptean Launches New, First-to-Market Antibody Search Solution to Support Biologics Research and Development

 

NewswireToday - /newswire/ - Alpharetta, GA, United States, 2020/10/26 - Unique Functionality Now Available within Aptean GenomeQuest, the World’s Leading Intellectual Property Sequence Database - Aptean.com. NASDAQ: TRMB

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Aptean, a global provider of mission-critical enterprise software solutions, announced the release of a new solution designed to help companies drastically improve their efficiency in important biologics research and development (R&D). This new tool, the GenomeQuest Antibody Module, is offered through Aptean GenomeQuest, the world’s leading intellectual property (IP) sequence database that combines a comprehensive patent landscape view with the most powerful search, analysis and reporting tools available.

Biologics have landed at the forefront of medical advances in recent years, with antibodies, in particular, being used in increasingly diverse applications, from vaccines to drugs for treating cancer, multiple sclerosis and other autoimmune and common diseases. According to a report by Global Industry Analysts, Inc., the global market for biologics is currently estimated at $292.2 billion and is projected to reach $505.6 billion by 2027 growing at a CAGR of 8.1% over seven years. The antibody treatment trend is unlikely to slow as scientists continue to explore new applications and learn to produce them at scale.

“With the growing focus on antibodies in medicine, it’s critical that companies developing these therapies protect their IP and R&D investments. However, searching for antibody sequences in the intellectual property landscape is notoriously difficult,” said Martin Wagstaff, Aptean’s group vice president of finance and life sciences products. “Searchers typically must perform up to eight separate searches, then spend days painstakingly combining the results to discover potential sequencing alignments. In addition to being deeply inefficient, this makes it challenging to confidently answer critical questions about antibody IP.”

Aptean’s unique GenomeQuest Antibody Module dramatically streamlines the process of antibody sequence search and increases productivity through its user-friendly search interface. Upon query completion, results are displayed in an interactive summary report featuring diagrams that enable users to drill down to patent documents and alignments with extreme ease and accessibility. This new solution provides clear and comprehensive answers to many critical IP questions, delivering more assurance to biologics and large molecule antibody treatment researchers that nothing has been overlooked.

Wagstaff continued,“Our leading IP sequence search database, GenomeQuest, is built upon high-performing proprietary technology, allowing Aptean to add innovations such as streamlined antibody and variation searching into the application. We are proud to be the first company offering this capability to the market and helping our customers protect their valuable investments.”

About Aptean

Aptean (aptean.com) is one of the world’s leading providers of industry-specific software. Our enterprise resource planning and supply chain solutions are uniquely designed to meet the needs of specialized manufacturers and distributors in over 20 industries, while our compliance solutions serve specific markets such as finance and life sciences. In total, Aptean’s solutions are used by over 5,000 customers around the world. With both cloud and on-premise deployment options, Aptean’s products, services and unmatched expertise help businesses of all sizes to scale and succeed. Aptean is headquartered in Alpharetta, Georgia and has offices in North America, Europe and Asia-Pacific.

Aptean is a trademark of Aptean, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: APTEAN

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


Aptean Launches New, First-to-Market Antibody Search Solution to Support Biologics Research and Development

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Nicole O’Rourke - Aptean.com 
770-715-0362 nicole.orourke[.]aptean.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any APTEAN securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From APTEAN / Company Profile


Read Software Most Recent Related Newswires:

Valley View Casino & Hotel Partners with Infor for Digital Transformation
SAP to Acquire Leading Working Capital Management Company Taulia
Mayo Clinic Selects Oracle Fusion Cloud Applications to Power Business Processes
SAP and Icertis Expand Partnership to Deliver Enterprise Contract Intelligence
Infor Announces New Infor Marketplace
New Oracle Cloud Infrastructure Services Authorized for the US Government
InterSystems Positioned in the Challengers Quadrant of the 2021 Gartner® Magic Quadrant™ for Cloud Database Management Systems
Oracle Opens First Cloud Region in Africa
Xerox Selects Oracle Cloud to Launch New Businesses Focused on Solving Complex Problems At Scale
Frost & Sullivan Selects KPIT Technologies for the Prestigious 2021 Global Over-the-air (OTA) & Cloud Platform Technology Innovation Leadership Award
Cornerstone Tops Industry Reports for Learning and Talent Experience Innovations
The Mill and MPC Advertising Unite Under the Mill Brand to Create the World’s Largest VFX Studio for the Advertising & Brand Experience Industries
Aptean Expands in Austria with Acquisition of JET ERP
Siemens Extends Mechanical Performance Prediction Leadership with Simcenter 3D 2022.1
Axiell Announces Agreement to Acquire Infor Library & Information Solutions Business and Expand Global Presence

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)